Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edward E Graves

Showing results (41-50 of 114) with videos related to

Pageof 12
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2012
Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canalJose G Bazan, Albert C Koong, Daniel S Kapp, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2015
Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcomeEdward E Graves, Rodney J Hicks, David Binns, et al.
Clinical Lung Cancer|March 16, 2015
Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic FactorsJeremy P Harris, Christine N Chang-Halpenny, Peter G Maxim, et al.
Sensors and Actuators. B, Chemical|April 9, 2020
An Activatable NIR Fluorescent Rosol for Selectively Imaging Nitroreductase ActivityJessica L Klockow, Kenneth S Hettie, Edward L LaGory, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2016
Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235Jose G Bazan, Fenghai Duan, Bradley S Snyder, et al.
NMR in Biomedicine|June 10, 2006
Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomasIsabelle Catalaa, Roland Henry, William P Dillon, et al.
Nucleic Acids Research|December 12, 2019
53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapyIris Eke, Dali Zong, Molykutty J Aryankalayil, et al.
Radiation Research|August 29, 2020
Evaluating the Reproducibility of Mouse Anatomy under Rotation in a Custom Immobilization Device for Conformal FLASH RadiotherapyRyan B Ko, Luis A Soto, Rie von Eyben, et al.
Scientific Reports|March 4, 2022
Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent mannerIris Eke, Molykutty J Aryankalayil, Michelle A Bylicky, et al.
Cancer Immunology, Immunotherapy : CII|August 26, 2021
Long-term expression changes of immune-related genes in prostate cancer after radiotherapyIris Eke, Molykutty J Aryankalayil, Michelle A Bylicky, et al.
Pageof 12

Showing results (41-50 of 114) with videos related to

Sort By:
Pageof 12
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 14, 2012
Metabolic tumor volume predicts disease progression and survival in patients with squamous cell carcinoma of the anal canalJose G Bazan, Albert C Koong, Daniel S Kapp, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 19, 2015
Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcomeEdward E Graves, Rodney J Hicks, David Binns, et al.
Clinical Lung Cancer|March 16, 2015
Outcomes of Modestly Hypofractionated Radiation for Lung Tumors: Pre- and Mid-Treatment Positron Emission Tomography-Computed Tomography Metrics as Prognostic FactorsJeremy P Harris, Christine N Chang-Halpenny, Peter G Maxim, et al.
Sensors and Actuators. B, Chemical|April 9, 2020
An Activatable NIR Fluorescent Rosol for Selectively Imaging Nitroreductase ActivityJessica L Klockow, Kenneth S Hettie, Edward L LaGory, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 21, 2016
Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235Jose G Bazan, Fenghai Duan, Bradley S Snyder, et al.
NMR in Biomedicine|June 10, 2006
Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomasIsabelle Catalaa, Roland Henry, William P Dillon, et al.
Nucleic Acids Research|December 12, 2019
53BP1/RIF1 signaling promotes cell survival after multifractionated radiotherapyIris Eke, Dali Zong, Molykutty J Aryankalayil, et al.
Radiation Research|August 29, 2020
Evaluating the Reproducibility of Mouse Anatomy under Rotation in a Custom Immobilization Device for Conformal FLASH RadiotherapyRyan B Ko, Luis A Soto, Rie von Eyben, et al.
Scientific Reports|March 4, 2022
Radiotherapy alters expression of molecular targets in prostate cancer in a fractionation- and time-dependent mannerIris Eke, Molykutty J Aryankalayil, Michelle A Bylicky, et al.
Cancer Immunology, Immunotherapy : CII|August 26, 2021
Long-term expression changes of immune-related genes in prostate cancer after radiotherapyIris Eke, Molykutty J Aryankalayil, Michelle A Bylicky, et al.
Pageof 12